# Iambic Therapeutics Inc. (IAM)

Source: https://www.quantisnow.com/company/IAM
Generated: 2026-11-08T19:09:46.986Z

- Ticker: IAM
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2026
- SEC CIK: 0001997038

## About

Iambic's mission is to make better technology for better medicines. By utilizing molecular superintelligence - integrating proprietary AI with automated, scalable chemistry and biology experimentation - our platform is designed to address the totality of drug discovery and development. We believe the utility of our platform is demonstrated by the discovery of IAM1363, a novel drug candidate advanced to clinic in approximately two years, along with a diverse preclinical pipeline. Our leading AI technologies include Enchant and NeuralPLexer for multimodal endpoint prediction designed to improve the speed, precision, and success rates of drug discovery and clinical development. At Iambic, we are building an engine that is designed to power the future of medicine.

## Latest IAM news and filings

No events on the wire yet.

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/IAM
- Earnings history: https://www.quantisnow.com/earnings/IAM
- Dividend history: https://www.quantisnow.com/dividends/IAM
- Insider transactions: https://www.quantisnow.com/insiders/IAM
- Options chain: https://www.quantisnow.com/options/IAM
- SEC 8-K filings only: https://www.quantisnow.com/company/IAM/8-k
- RSS and alerts for IAM: https://www.quantisnow.com/docs/rss-feeds.md